lisuride has been researched along with Nerve Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Double, KL; Gerlach, M; Griffiths, FM; Halliday, GM; Heinemann, T; Henderson, J; Riederer, P | 1 |
| Allain, H; Bentue-Ferrer, D; Caldwell, MA; Leonard, BE; Reymann, JM | 1 |
| Eising, EG; Jacob, M; Kuhn, W; Müller, T; Przuntek, H; Reiners, C | 1 |
3 other study(ies) available for lisuride and Nerve Degeneration
| Article | Year |
|---|---|
The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration.
Topics: Aerobiosis; Animals; Behavior, Animal; Brain Chemistry; Cell Survival; Dopamine; Dopamine Agonists; Iron; Lisuride; Male; Melanins; Neostriatum; Nerve Degeneration; Neuroprotective Agents; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2003 |
The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following 4-vessel occlusion in the rat.
Topics: Animals; Behavior, Animal; Brain; Brain Ischemia; Dopamine Agonists; Hippocampus; Lisuride; Male; Maze Learning; Muscle, Skeletal; Nerve Degeneration; Piribedil; Rats; Rats, Wistar; Receptors, Dopamine D2 | 1996 |
2-[123I]-iodolisuride SPET visualizes dopaminergic loss in de-novo parkinsonian patients: is it a marker of striatal pre-synaptic degeneration?
Topics: Aged; Brain; Cerebellum; Corpus Striatum; Dopamine; Female; Functional Laterality; Humans; Iodine Radioisotopes; Lisuride; Male; Middle Aged; Nerve Degeneration; Organ Specificity; Parkinson Disease; Regression Analysis; Synapses; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1997 |